Dis-Chem Pharmacies Ltd
JSE:DCP
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2 810
3 729
|
| Price Target |
|
We'll email you a reminder when the closing price reaches Zac.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Dis-Chem Pharmacies Ltd
Gross Profit
Dis-Chem Pharmacies Ltd
Gross Profit Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
Gross Profit
8.8B
|
CAGR 3-Years
9%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
Dis-Chem Pharmacies Ltd
Glance View
Dis-Chem Pharmacies Ltd., a notable player in South Africa's pharmaceutical landscape, has navigated a path of consistent growth since its inception in 1978. Founded by Ivan and Lynette Saltzman, the company emerged as a disruptor in the pharmacy retail sector by fusing exceptional customer service with an expansive range of wellness products. The Saltzmans began with a single pharmacy in Mondeor, Gauteng, but their vision quickly materialized into a nation-spanning network of outlets. Today, Dis-Chem stands as one of the country's leading pharmacy groups, offering a broad spectrum of healthcare and personal care products, grouped conveniently under one roof to appeal to a growing health-conscious consumer base. At the core of Dis-Chem's business model is its value proposition of offering a diversified array of products that ranges from prescription medication to cosmetics and nutraceuticals. Unlike standard pharmacies, Dis-Chem operates a strategic retail footprint that not only sells health services and products but also engages in wholesale distribution through its integrated warehouse facilities. This vertically integrated approach allows Dis-Chem to maintain competitive pricing while optimizing supply chain efficiencies. The company, thereby, successfully generates revenue through both direct consumer sales and wholesale distribution to independent pharmacies, driving consistent profitability and reinforcing its standing as a trusted healthcare provider to the South African populace.
See Also
What is Dis-Chem Pharmacies Ltd's Gross Profit?
Gross Profit
8.8B
ZAR
Based on the financial report for Feb 28, 2025, Dis-Chem Pharmacies Ltd's Gross Profit amounts to 8.8B ZAR.
What is Dis-Chem Pharmacies Ltd's Gross Profit growth rate?
Gross Profit CAGR 5Y
10%
Over the last year, the Gross Profit growth was 7%. The average annual Gross Profit growth rates for Dis-Chem Pharmacies Ltd have been 9% over the past three years , 10% over the past five years .